Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Q4 operating loss widens to SEK 2.2 mln

Feb 24 (Reuters) - Corline Biomedical AB  CLBIO.ST : 
    * Q4 net sales 150,000 Swedish crowns ($17,636) versus 677,000 crowns year ago 
    * Q4 operating loss 2.2 million crowns versus loss 0.6 million crowns year ago 
 
     
Source text for Eikon:  ID:nHUG5SQNDT  
     
Further company coverage:  CLBIO.ST  
 
($1 = 8.5051 Swedish crowns) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Corline Biomedical AB

See all news